Pharmacology & ToxicologybioRxivPreprint
CTLA-4 inhibitors drive colitis through metabolic reprogramming-mediated Treg/Th17 imbalance
Zhiying Li, Shanna Wu, Rongchen Liu…·Yiru Long
This study identifies metabolic reprogramming as a mechanism by which CTLA-4 inhibitors cause colitis, showing that metformin can alleviate this toxicity without affecting antitumor efficacy.
DOI 10.64898/2026.01.20.700699